Exhaled breath analysis by ion mobility spectrometry in children with asthma and cystic fibrosis

M. Bannier (Maastricht, Netherlands), K. Van De Kant (Maastricht, Netherlands), J. Baumbach (Reutlingen, Germany), Q. Jobsis (Maastricht, Netherlands), E. Dompeling (Maastricht, Netherlands), S. Barnowski (sandra.barnowski@dbmr.unibe.ch / Department for Biomedical Research, B. University Hospital, B. , C. , A. Stokes (Andrea.Stokes@insel.ch / Department for Biomedical Research, B. University Hospital, B. , C. , T. Geiser (Thomas.Geiser@insel.ch / Department for Biomedical Research, B. University Hospital, B. , C. , L. Knudsen (knudsen.lars@mh-hannover.de / Functional and Applied Anatomy Medical School Hannover,Hannover), M. Funke-Chambour (Manuela.Funke-Chambour@insel.ch / Department for Biomedical Research, B. University Hospital, B. , C.

Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Session: Cystic fibrosis in paediatric patients: current research
Session type: Thematic Poster
Number: 4613
Disease area: Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Bannier (Maastricht, Netherlands), K. Van De Kant (Maastricht, Netherlands), J. Baumbach (Reutlingen, Germany), Q. Jobsis (Maastricht, Netherlands), E. Dompeling (Maastricht, Netherlands), S. Barnowski (sandra.barnowski@dbmr.unibe.ch / Department for Biomedical Research, B. University Hospital, B. , C. , A. Stokes (Andrea.Stokes@insel.ch / Department for Biomedical Research, B. University Hospital, B. , C. , T. Geiser (Thomas.Geiser@insel.ch / Department for Biomedical Research, B. University Hospital, B. , C. , L. Knudsen (knudsen.lars@mh-hannover.de / Functional and Applied Anatomy Medical School Hannover,Hannover), M. Funke-Chambour (Manuela.Funke-Chambour@insel.ch / Department for Biomedical Research, B. University Hospital, B. , C.. Exhaled breath analysis by ion mobility spectrometry in children with asthma and cystic fibrosis. 4613

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Phenotyping of patients with COPD from exhaled air by ion mobility spectrometry
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012

Differential ion mobility spectrometry for detection of metabolites in exhaled breath in airway diseases
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009

Detection of infectious agents in the airways by ion mobility spectrometry in exhaled breath
Source: Annual Congress 2010 - Mechanisms of respiratory infections
Year: 2010


SELDI-TOF MS for proteomic analysis of exhaled breath condensate from patients with pulmonary emphysema
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009

Conductivity in exhaled breath condensate of patients with asthma, COPD or cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 227s
Year: 2005

Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis
Source: Eur Respir J 2006; 27: 929-936
Year: 2006



Discrimination of protein and peptide composition of exhaled breath condensate in patients with pulmonary disease by mass spectrometry
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011


Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 468s
Year: 2004

Ionic composition of exhaled breath condenesate in cystic fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 8s
Year: 2001

Adaptation of differential ion mobility spectrometry (DMS) for discrimination of specific biomarkers in exhaled breath in patients with severe renal-pulmonary dysfunction
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011


Breath analysis by ion mobility spectrometry in COPD and lung cancer patients
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009


Determination of volatile organic compounds in exhaled breath of patients with chronic obstructive pulmonary disease by gas chromatography mass spectrometry
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010


High performance liquid chromatography analysis of nitrosothiols and nitrite in exhaled breath condensate in asthmatic children
Source: Eur Respir J 2006; 28: Suppl. 50, 258s
Year: 2006

Exhaled breath temperature in adult cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Year: 2011


Clusters of biomarkers in exhaled breath detected by differential ion mobility spectrometry (DMS)
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011


Processing optimization of exhaled breath condensate previous to the analysis by mass spectrometry
Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests
Year: 2012


Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010


Ion mobility spectrometry in medical diagnostics: proof of inflammation markers in different parliamentary groups of the exhaled breath
Source: Annual Congress 2008 - Assessment of the respiratory system
Year: 2008

Human skin keratins are the major proteins in exhaled breath condensate
Source: Eur Respir J 2008; 31: 380-384
Year: 2008



Correlation of FENO with nitrites and nitrates in exhaled breath condensate in cystic fibrosis patients
Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Year: 2007